
Rifaximin Coupons & Discount Card - Compare Prices Near You
generic Xifaxan
My prescription
Edit
100GM of 1, Rifaximin (1 Bottle)
Select pharmacy

CVS
$772.40
COUPON PRICE
Rite Aid
$754.61
COUPON PRICE
Walmart
$776.81
COUPON PRICE
Walgreens
$787.80
COUPON PRICERifaximin savings card
Show this card to your pharmacist
CVS
$772.40
BIN
ID
PCN
GRP
019876
LHE65F4CA8
CHIPPO
LHX
Powered by
Rifaximin dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
100GM of 1 | 1 Bottle | $772.4 | $772.4 |
Rifaximin Warnings
The following information outlines important safety considerations and warnings associated with this medication. It is crucial to carefully read and understand these details. Should you have any questions or concerns, please consult your healthcare provider.
Worsening of Travelers' Diarrhea: Xifaxan (rifaximin) is effective in treating travelers' diarrhea caused by the E. coli bacteria. However, it may not be effective against other bacteria that can cause similar symptoms, potentially leading to a worsening condition if not treated correctly.
Diarrhea from Clostridioides difficile Infection: Like other antibiotics, Xifaxan (rifaximin) may disrupt the normal bacterial balance in the stomach and intestines, potentially leading to an overgrowth of Clostridioides difficile (C. diff). This can result in severe and potentially life-threatening diarrhea. The risk increases with the use of antibiotics.
Contraindications: This medication should not be used under certain conditions due to potential serious health risks. If you fall under any of these categories, discuss with your healthcare provider before taking this medication.
- Severe allergy to Xifaxan (rifaximin), rifampin (Rifadin), or rifabutin (Mycobutin).
Always consult your healthcare provider for personalized medical advice and before making any changes to your medication regimen.
Rifaximin Side Effects
Common side effects:
- Headaches
Less common but important to monitor:
- Nausea
Serious side effects:
- Significant swelling in the hands and feet
- Severe nausea
- Dizziness
- Notable sense of tiredness
- Extra stomach fluid and swelling
Why is rifaximin used in liver disease?
Rifaximin is used in liver disease primarily to treat hepatic encephalopathy. It helps reduce the risk of episodes by decreasing the production of ammonia and other toxins by gut bacteria, which can accumulate due to impaired liver function. This reduction in toxins helps improve mental status and quality of life in patients with liver disease.
Is rifaximin a strong antibiotic?
Rifaximin is considered a broad-spectrum antibiotic, primarily used to treat certain gastrointestinal infections. It is effective against a wide range of bacteria, particularly those in the gut, but its strength is relative to its specific use and the type of infection being treated. It is not typically used for systemic infections as it is minimally absorbed into the bloodstream.
What does Xifaxan do for your gut?
Xifaxan is an antibiotic that targets the gut. It is primarily used to treat certain bacterial infections in the intestines, such as traveler's diarrhea caused by non-invasive strains of Escherichia coli. Additionally, it is used to manage irritable bowel syndrome with diarrhea (IBS-D) and to reduce the risk of overt hepatic encephalopathy recurrence in patients with liver disease. By acting locally in the gut, Xifaxan helps to reduce harmful bacteria and alleviate symptoms associated with these conditions.
What is rifaximin used to treat?
Rifaximin is used to treat traveler's diarrhea caused by non-invasive strains of Escherichia coli. It is also used to reduce the risk of overt hepatic encephalopathy recurrence in adults and to treat irritable bowel syndrome with diarrhea (IBS-D) in adults.
What is the new drug for cirrhosis of the liver?
As of the latest information, there is no single "new drug" specifically approved for the treatment of cirrhosis of the liver. Treatment typically focuses on managing the underlying cause of the cirrhosis, such as antiviral medications for hepatitis or lifestyle changes for alcohol-related liver disease. However, research is ongoing, and new therapies are being investigated to address liver fibrosis and cirrhosis. It is important for patients to consult with their healthcare provider for the most current treatment options available.